"Deceptive Advertising!" Claims Novo Nordisk in Explosive New GLP-1 Lawsuit Against Eli Lilly.The Motley Fool • 07/21/26
Novo Nordisk's Dividend Story Is Changing -- Here's What Investors Are MissingThe Motley Fool • 07/21/26
Novo Nordisk filed a lawsuit against rival Eli Lilly accusing it of using outdated studies to promote its GLP-1 drugsWSJ • 07/21/26
Watch Out, Eli Lilly and Novo Nordisk: Viking Therapeutics Just Started Testing a Weight Loss Drug That Goes Beyond GLP-1The Motley Fool • 07/18/26
The First Oral Cholesterol Pill Is Here. Which of These 5 Stocks Benefits Most?24/7 Wall Street • 07/17/26
Novo Nordisk (NVO) Ascends While Market Falls: Some Facts to NoteZacks Investment Research • 07/16/26
Medicare's $50 Weight-Loss Drug Window Opens In July: What Smart Enrollees Do Before 2027Benzinga • 07/16/26
The Next Wave Of Peptides Could Be Here; What Does It Mean For Lilly, Novo?Investors Business Daily • 07/16/26